Hardin Scientific Locates Manufacturing-Development Campus in Greensburg, Kentucky
01/26/2018
The company will locate in a 40,000-square-foot spec building in Greensburg, 74 miles northeast of Bowling Green, where it will manufacture T3-i7 Cell-Culture incubators, the first modular and internet-enabled device on the company’s platform. The device enables accurate reproduction of human-like body conditions for tissue culture, stem-cell research, protein expressions and genetics in the research, diagnostic and forensic industries.
Founder & CEO Aaron Hardin, a Berea, Kentucky native, noted the Greensburg community’s hospitality and the logistical advantages of locating in Kentucky as major factors in the company decision.
“There is a technological void in the life sciences; the people creating life-saving treatments and pharmaceuticals rely on outdated equipment,” Hardin said. “What they do with the tools they have is truly amazing, and I look forward to what they can accomplish with 21st Century solutions. Bringing this project to Kentucky makes good business sense and the ability to stimulate economic growth in my home state feels right. We received two dozen state and city proposals and searched the globe, but I can’t think of a more dedicated, harder working and humble labor force available.”
To encourage the investment and job growth in the community, the Kentucky Economic Development Finance Authority (KEDFA) in January preliminarily approved the company for tax incentives up to $1 million through the Kentucky Business Investment program. The performance-based incentive allows a company to keep a portion of its investment over the agreement term through corporate income tax credits and wage assessments by meeting job and investment targets. In addition, Hardin Scientific can receive resources from the Kentucky Skills Network.
Hardin founded the company in 2016 with the mission to reduce human suffering through the elimination of disease, removal of barriers and an increase in the rate of discovery. He said the impetus for creating Hardin Scientific was a realization that “innovators weren’t being innovated,” noting the primary reason for high-cost prescription drugs is that equipment used in developing medications has become obsolete.
Hardin Scientific’s T3-i7 technology helps to reduce the gap between equipment and treatment technology. Its patented health-monitoring system helps to safeguard samples and ensure a higher level of safety and security.
“Hardin Scientific combines cutting-edge science with the kind of business initiative we want to encourage more of in Kentucky,” said Governor Matt Bevin. “Companies like this are fueling our state’s rise to national distinction in research and advanced manufacturing. It is the entrepreneurs with big ideas, like those guiding Hardin Scientific, that are making this happen. It is great to see a homegrown product of one of Kentucky’s universities leading the way as we move into the future.”
Project Announcements
United Arab Emirates-Based Hotpack Plans Edison, New Jersey, Manufacturing Operations
05/12/2025
SSAB Expands Axis, Alabama, Production Operations
05/12/2025
Carnival Corporation Plans Miami, Florida, Headquarters Operations
05/12/2025
Merck Animal Health Expands De Soto, Kansas, Manufacturing Operations
05/12/2025
Oxford Technologies Plans Bay County, Florida, Manufacturing Operations
05/12/2025
PPG Plans Shelby, North Carolina, Manufacturing Operations
05/12/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024